[MDGL] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
31-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 29.62%
YoY- -8.33%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 62,175 0 0 0 0 0 0 -
PBT -106,964 -98,740 -81,197 -63,100 -57,963 -21,429 -8,512 52.41%
Tax 0 -135 1,502 0 0 0 0 -
NP -106,964 -98,740 -82,699 -63,100 -57,963 -21,429 -8,512 52.41%
Tax Rate - - - - - - - -
Total Cost 169,139 98,740 82,699 63,100 57,963 21,429 8,512 64.50%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -172.04 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -4.92 -5.34 -4.84 -3.79 -3.75 -1.39 -0.56 43.59%
EPS Diluted -4.92 -5.34 -4.84 -3.79 -3.75 -1.39 -0.56 43.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.